Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism-Reference-Cited by-同舟云学术

Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism

Published:2017-03 Issue:2 Volume:16 Page:207-214
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Saeedi Ramesh,Mojebi-Mogharar Ali,Sandhu Supna K.,Dubland Joshua A.,Ford Jo-Ann,Yousefi Masoud,Pudek Morris,Holmes Daniel T.,Erb Siegfried R.,Peter Kwan Wing C.,Kendler David L,Yoshida Eric M.

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Link

https://publisherspanel.com/icid/pdf/1231580

Reference19 articles.

1. Treatment of hepatitis B in decompensated liver cirrhosis;Gua;Int J Hepatol,2011

2. Long-term efficacy and safety of lami-vudine, entecavir, and tenofovir for treatment of hepatitis b virus-related cirrhosis;Köklü;Clin Gastroenterol Hepatol,2013

3. Chronic hepatitis B: A treatment update;Wong;Semin Liver Dis,2013

4. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open label follow-up study;Marcellin;Lancet,2013

5. Side effects of long-term oral antiviral therapy for hepatitis B;Fontana;Hepatology,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Pharmacokinetics of a BCS Class III Drug with Two Different Study Designs: Tenofovir Alafenamide Monofumarate Film-coated Tablet;AAPS PharmSciTech;2024-05-30

2. Osteoporosis in patients with hepatitis B receiving tenofovir disoproxil fumarate: Does fibroblast growth factor 23 play a role?;Journal of Hepatology;2024-05

3. Comparison of renal safety and bone mineral density of tenofovir and entecavir in patients with chronic hepatitis B: a systematic review and meta-analysis;International Journal of Infectious Diseases;2022-11

4. Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study;Hepatology International;2022-06-14

5. Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response;Journal of Viral Hepatitis;2021-07-20